Brief: Procisedx Secures $10.5 Million Series A Financing Round Led By Biosynex, Forms An Independent Point-Of-Care Diagnostic Company
July 21 (Reuters) - Biosynex SA ALBIO.PA :
* PROCISEDX SECURES $10.5 MILLION SERIES A FINANCING ROUND
LED BY
BIOSYNEX, FORMS AN INDEPENDENT POINT-OF-CARE DIAGNOSTIC COMPANY
* PROCISEDX INC - RAISED $10.5 MILLION THROUGH $8.5 MILLION
OF
EQUITY, $2 MILLION OF DEBT, IN SERIES A FINANCING ROUND LED BY
BIOSYNEX
Source text for Eikon: ID:nPn6r1LGva
Further company coverage: ALBIO.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals